TIMM8A and lung carcinoma: In conclusion, this study demonstrates that components of the TIMM8A-TIMM13 complex exhibit elevated expression and potentially contribute to disease progression and poor outcomes in lung cancer patients through upregulation of CCND1 and CDK6.